Heart Failure With Preserved Ejection Fraction trials recruiting in New York

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in New York

Recruiting trials in New York

• A Preliminary Study for INFORMED
  NCT05585125 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · New York: New York
• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · New York: New York
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo, New York, Poughkeepsie
• Incretin Therapies in Obesity-related HFpEF
  NCT07554638 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Albany, New York, Poughkeepsie, Staten Island
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · New York: Buffalo, Manhasset, New York